Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

Real-time Estimate Tradegate 05:35:48 2024-06-06 am EDT 5-day change 1st Jan Change
39.24 EUR +0.19% Intraday chart for Fresenius Medical Care AG +0.46% +3.37%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dpa-AFX Overview: COMPANIES from 05.06.2024 - 15:15 DP
Fresenius raises targets for hospital business - shares up DP
Fresenius driven by higher Helios targets DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs keeps its Buy rating ZD
Fresenius lifts 2024 targets for private healthcare unit Helios RE
Fresenius chart breakout fails before capital market day DP
FMC briefly burdened by research success in the fight against diabetes DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Berenberg reaffirms its Buy rating ZD
European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan remains a Sell rating ZD
FMC, Fresenius and Davita rise after Ozempic news DP
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from JP Morgan ZD
Life Healthcare Group Holdings Limited agreed to acquire Assets and Operations of 51 Renal Dialysis Clinics of Fresenius Medical Care AG. CI
Moody’s Revises Outlook on Fresenius Medical Care to Stable from Negative MT
Moody’s Affirms Fresenius' Rating, Outlook on Improving Profitability MT
Truist Securities Adjusts Price Target on Fresenius Medical Care to $24 From $21, Maintains Hold Rating MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Sell rating from Jefferies ZD
Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank... Our Logo
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Buy rating from Berenberg ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reiterates its Neutral rating ZD
FRESENIUS MEDCARE : adjusted target price at Barclays CF
Fresenius Medical sees up to 2% US dialysis growth by year-end RE
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3% MT
Chart Fresenius Medical Care AG
More charts
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.17 EUR
Average target price
39.97 EUR
Spread / Average Target
+2.05%
Consensus
  1. Stock Market
  2. Equities
  3. FME Stock
  4. News Fresenius Medical Care AG
  5. Sector Update: Health Care Stocks Lower Tuesday Afternoon